Boehringer Ingelheim, Cue Biopharma partner to develop next generation treatment for autoimmune, inflammatory diseases Ruchika Sharma16 April 2025 10:30 AM ISTBoston: Boehringer Ingelheim and Cue Biopharma, Inc. have announced a strategic research collaboration and license agreement to develop and...
Bristol Myers Squibb heart disease drug fails to meet main goals in late-stage study Ruchika Sharma16 April 2025 9:30 AM ISTPrinceton: Bristol Myers Squibb has announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult...
Mankind Pharma to constitute committee to evaluate ways to integrate BSV Ruchika Sharma15 April 2025 5:17 PM ISTNew Delhi: Mankind Pharma has announced that the Board of Directors of the Company at its meeting has inter-alia, considered and approved the...
Biocon Biologics secures market entry date for ophthalmology drug Yesafili in US Ruchika Sharma15 April 2025 4:18 PM ISTAdditionally, Biocon Biologics secured a settlement agreement in Canada with Bayer and Regeneron Pharma for launch of YESAFILI no later than July 1,...
AstraZeneca Pharma India surrenders marketing authorisation for specific indication of Olaparib Ruchika Sharma15 April 2025 3:46 PM ISTBangalore: AstraZeneca Pharma India Limited has surrendered its marketing authorisation for Olaparib film-coated tablets 100mg and 150mg...
Delhi: Counterfeit Thrombophob Ointments worth over Rs 2.5 Lakh seized following Zydus Healthcare complaint Ruchika Sharma15 April 2025 12:49 PM ISTNew Delhi: Acting on a complaint filed by pharmaceutical major Zydus Healthcare Limited, the Drugs Control Department of the Delhi government has...
Johnson & Johnson MedTech completes first cases with OTTAVA Robotic Surgical System Ruchika Sharma15 April 2025 11:45 AM ISTUpon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the United States.
"Who's going to pay price to bring back manufacturing in US", asks Biocon MD Ruchika Sharma15 April 2025 10:30 AM ISTNew Delhi: Siddharth Mittal, the CEO and Managing Director of Biocon Limited, raised a critical question on Friday, asking who would bear...
Rs 1 Cr Plus Earners in Firing Line as Dr Reddy's Targets 25% Cost Cut, May Shut Digital Unit Farhat Nasim14 April 2025 6:43 PM ISTHyderabad: In a strategic move to enhance operational efficiency, pharmaceutical giant Dr Reddy's Laboratories (DRL) has initiated a significant cost...
PCI Issues Special Inspection Guidelines for 2025-2026 academic session Dr. Divya Colin14 April 2025 6:15 PM ISTNew Delhi: The Pharmacy Council of India (PCI) has recently issued a circular providing special guidelines for approved inspectors and pharmacy...
Pfizer discontinues development of danuglipron for chronic weight management Ruchika Sharma14 April 2025 5:41 PM ISTNew York: Pfizer Inc. has announced the company has discontinued the development of danuglipron (PF-06882961), an oral glucagon-like...
Multi-drug resistant infections medicine 'Zaynich' to get USFDA approval next year: Wockhardt Chairman Ruchika Sharma14 April 2025 3:49 PM ISTDubai: Zaynich, a multi-drug resistant infections medicine, is set to receive the US Food and Drug Administration (USFDA) approval in 2026,...
